Target intelligence / Profile preview

Microbial cell membrane and cellular envelope

Molecular classification
Other
01

Overview

The microbial cell membrane and cellular envelope are essential structural components that define the boundary and maintain the viability of bacteria and fungi (Silhavy et al., 2010). In bacteria, the envelope typically consists of an inner cytoplasmic membrane and a peptidoglycan cell wall, while Gram-negative bacteria also possess an outer membrane containing lipopolysaccharides (Silhavy et al., 2010). Fungal envelopes are characterized by a plasma membrane rich in ergosterol and a complex cell wall made of chitin, glucans, and mannoproteins (Gow et al., 2017). These structures provide osmotic protection, facilitate nutrient acquisition, and serve as scaffolds for vital enzymatic processes (Kohanski et al., 2010). Because many of these components, such as peptidoglycan and ergosterol, are absent in human cells, they are highly effective targets for selective toxicity (Odds et al., 2003). Antibiotics like penicillins and vancomycin target cell wall synthesis, whereas polymyxins and polyene antifungals like amphotericin B disrupt membrane integrity (StatPearls, 2023). Despite their success, targeting the microbial envelope faces challenges from emerging resistance, such as modified peptidoglycan precursors or altered membrane charge (NIH, 2023). Overall, the microbial envelope remains a primary focus for developing new antimicrobial agents to combat multi-drug resistant pathogens.

Other names
Bacterial cell wallFungal cell wallCytoplasmic membranePlasma membranePeptidoglycan layerOuter membraneErgosterol-containing membraneBacterial cell envelopeFungal cell envelope
02

Mechanism of action

Inhibition of peptidoglycan synthesis, disruption of membrane integrity, pore formation, and inhibition of cell wall component biosynthesis.

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityNeurotoxicityInfusion-related reactionsAntimicrobial resistanceMicrobiome disruption
06

Interacting drugs

Penicillin G

5 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)1,3-beta-D-glucanGalactomannan

Beyond the preview

Go deeper on Microbial cell membrane and cellular envelope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membrane and cellular envelope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call